
The nomination of tech critic Lina Khan to the Federal Trade Commission (FTC) will move to a full Senate vote after a committee voted Wednesday, May 12, to report the nomination favorably, reported MSN.
Only four Republican members of the Senate Commerce Committee voted against the measure: Sens. Marsha Blackburn (Republican – Tennessee), Mike Lee (Republican – Utah), Cynthia Lummis (Republican – Wyoming), and Dan Sullivan (Republican – Alaska).
Blackburn and Lee in particular had previously expressed skepticism about Khan’s nomination, pointing to what they said was a lack of experience. At 32, Khan would be the youngest commissioner to serve, if confirmed.
But the committee’s top Republican, Sen. Roger Wicker (Republican – Mississippi) voiced optimism in Khan’s nomination ahead of Wednesday’s vote.
“I believe she is focused on addressing one of the most pressing issues of the day: reining in the big social media platforms,” he said. “However, I do remain concerned that a broadly over-regulatory approach as an FTC commissioner could have a negative effect on the economy and undermine free market principles.”
Khan made her name in antitrust circles after publishing “Amazon’s Antitrust Paradox” in the Yale Law Journal while a student in 2017. The article examined the ways that the commonly-used consumer welfare standard, often defined by looking at whether prices go up or down, could miss important anticompetitive behavior in digital markets like the one in which Amazon operates.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas